Study Evaluating The Long-Term Safety And Efficacy Of Subcutaneous Bapineuzumab

Clinical trial NCT00916617 · TERMINATED

Trial details

NCT number: NCT00916617
Sponsor: Pfizer
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Alzheimer Disease

Start date: 2009-06-01
Primary completion: 2012-09-01
Enrollment: 62

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.